Patents for A61P 25 - Drugs for disorders of the nervous system (183,225)
12/2007
12/13/2007CA2687118A1 Methods of using low-dose doxepin for the improvement of sleep
12/13/2007CA2654512A1 Low dose sublingual tablets of opioid analgesics and preparation process
12/13/2007CA2654147A1 Muscarinic receptor agonists that are effective in the treatment of pain, alzheimer's disease and schizophrenia
12/13/2007CA2654138A1 Novel compounds
12/13/2007CA2653940A1 Substituted pyridyl amide compounds as modulators of the histamine h3 receptor
12/13/2007CA2653827A1 Novel blonanserin tape preparation
12/13/2007CA2653774A1 2-thioxanthine derivatives acting as mpo-inhibitors
12/13/2007CA2653498A1 Treatment of pain disorders with trans 4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydro-1-naphthalenamine and its formamide
12/13/2007CA2653424A1 Novel indazole derivative having spiro ring structure in side chain
12/13/2007CA2653345A1 Ibudilast for inhibiting macrophage migration inhibitory factor (mif) activity
12/13/2007CA2653238A1 Pyrrolidine derivatives useful as bace inhibitors
12/13/2007CA2651550A1 Fused, tricyclic sulfonamide inhibitors of gamma secretase
12/13/2007CA2650082A1 1-sulfonylindazolylamine and -amide derivatives as 5-hydroxytryptamine-6 ligands
12/13/2007CA2644922A1 Compositions comprising human embryonic stem cells and their derivatives, methods of use, and methods of preparation
12/12/2007EP1865067A1 Method for study, determination or evaluation
12/12/2007EP1864997A1 ROR ALPHA PROMOTING THE INDUCTION OF Bmal1 EXPRESSION
12/12/2007EP1864986A1 Pyrazolopyrimidine derivative or pharmaceutically acceptable salt thereof
12/12/2007EP1864975A2 Novel compounds
12/12/2007EP1864967A1 Method for preparing O-desmethyl-venlafaxine
12/12/2007EP1864678A1 Pigment epithelium-derived factor: characterization, genomic organization and sequence of the PEDF gene
12/12/2007EP1864675A1 Orally administered peptides to ameliorate atherosclerosis
12/12/2007EP1864666A1 Protective agent for retinal neuronal cell containing prostaglandin f2 alpha derivative as active ingredient
12/12/2007EP1864659A1 Lignane compound-containing oil-in-water emulsion and composition comprising the same
12/12/2007EP1864131A2 Natural ligand of g protein coupled receptor rcc356 and uses thereof
12/12/2007EP1863903A1 Preparation of autologous haematopoietic stem cells, the methods of production, cyropreservation and use for therapy of traumatic diseases of the central nervous system
12/12/2007EP1863819A2 Diazabicyclic aryl derivatives and their use as chinolinergic ligands at the nicotinic acetylcholine receptors
12/12/2007EP1863818A1 Acetylenyl-pyrazolo-pvrimidine derivatives as mglur2 antagonists
12/12/2007EP1863810A1 NOVEL TETRAHYDRO-1H-PYRIDO [4,3-b] INDOLE DERIVATIVES AS CB1' RECEPTOR LIGANDS
12/12/2007EP1863806A1 Amorphous ziprasidone mesylate
12/12/2007EP1863791A1 2-oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl-piperidines used as cgrp antagonists
12/12/2007EP1863785A1 Novel thiophene sulfoximines for treating cmplement-mediated deseases and conditions
12/12/2007EP1863784A1 Substituted aminoalkyl- and amidoalkyl-benzopyran derivatives
12/12/2007EP1863782A1 2-(n-methyl-propanamine)-3-(2-naphtol) thiophene, an imputity of duloxetine hydrochloride
12/12/2007EP1863771A2 Benzazole derivatives, compositions, and methods of use as b-secretase inhibitors
12/12/2007EP1863767A1 Metabolites for nk-i antagonists for emesis
12/12/2007EP1863757A2 Amide derivatives as ion-channel ligands and pharmaceutical compositions and methods of using the same
12/12/2007EP1863510A1 Methods for treating parkinson's disease
12/12/2007EP1863490A2 Muscarinic modulators
12/12/2007EP1863487A2 Treatment of parkinson's disease, obstructive sleep apnea, dementia with lewy bodies, vascular dementia with non-imidazole alkylamines histamine h3-receptor ligands
12/12/2007EP1863485A2 Alpha7 neuronal nicotinic receptor ligand and antipsychotic compositions
12/12/2007EP1863473A1 Novel use of lignan compounds
12/12/2007EP1863464A1 O-desmethylvenlafaxine and bazedoxifene combination product and uses thereof
12/12/2007EP1863461A2 Sirtuin related therapeutics and diagnostics for neurodegenerative diseases
12/12/2007EP1863360A1 Food composition for binding acetaldehyde in mouth and in digestive track, and method for the preparation of the composition
12/12/2007EP1549314B1 Use of brimonidine in the treatment of dementia and parkinsons disease
12/12/2007EP1505976B1 Synergistic combination of an opioid analgesic and a nsaid
12/12/2007EP1492794B1 Piperazine substituted aryl benzodiazepines and their use as dopamine receptor antagonists for the treatment of psychotic disorders
12/12/2007EP1474414B1 Dihydro-thia-phenanthrene-carbonyl-guanidines, method for the production thereof, use thereof as a medicament or diagnostic reagent
12/12/2007EP1442133B1 Use of Mirtazapine for improving the therapeutic response of humans having major depression and carrying the gene for apolipoprotein E4
12/12/2007EP1327630B1 New derivatives of cyano-aryl (or cyanoheteroaryl)-carbonyl-piperazinyl-pyrimidines, their preparation and application as medication
12/12/2007EP1309618B1 Leucine-based motif and clostridial neurotoxins
12/12/2007EP1276738B1 2-amino-3-(alkyl)-pyrimidone derivatives as gsk3.beta. inhibitors
12/12/2007EP1143943B1 USE OF p53 INHIBITORS FOR THE TREATMENT OF SIDE EFFECTS OF CANCER THERAPY
12/12/2007CN101087778A Pyrrolidyl derivatives of heteroaromatic compounds as phosphodiesterase inhibitors
12/12/2007CN101087771A Substituted N-sulfonylaminobenzyl-2-phenoxyacetamide compounds
12/12/2007CN101087763A Therapeutic agents
12/12/2007CN101087760A Crystalline aripiprazole solvates
12/12/2007CN101087619A Method of treatment or prophylaxis
12/12/2007CN101087610A Arylpiperazine derivatives and use thereof as 5-HTLA receptor ligands
12/12/2007CN101087599A 1-aminocyclohexane derivatives for the treatment of multiple sclerosis, emotional lability and pseudobulbar affect
12/12/2007CN101087597A Use of certain biphenyl compounds for protection of neurons and oligodendrocytes in the treatment of multiple sclerosis (MS)
12/12/2007CN101085793A Helicid new medicine containing 1,3,4-oxdiazole heterocycle with sedative activity and preparing method thereof
12/12/2007CN101085759A Amino-phthalazinone derivatives active as kinase inhibitors, process for their preparation and pharmaceutical compositions containing them
12/12/2007CN101085315A Chinese patent medicine for treating menstrual migraine
12/12/2007CN101085311A Traditional Chinese medicine composition for treating moody state during menstruation
12/12/2007CN101085306A Oral administration medicament for treating depression
12/12/2007CN101085246A Tea containing lotus heart and white peony root
12/12/2007CN101085245A Tea capable of clearing away heart-fire and tranquilizing mind
12/12/2007CN101085237A Internal-applied traditional Chinese medicine composition for treating neurasthenia
12/12/2007CN101085231A Internal-applied traditional Chinese medicine composition for treating depression
12/12/2007CN101085214A Method for preparing nurse-comforting capsule
12/12/2007CN101085203A Traditional Chinese medicine preparation for treating emotion abnormal during menstruation
12/12/2007CN101085196A Internal-applied traditional Chinese medicine composition for treating neurasthenia
12/12/2007CN101085195A Traditional Chinese medicine formula for treating children night terrors and sleep-walking
12/12/2007CN101085187A Lily medicine wine
12/12/2007CN101085135A High-efficient lozenge for stopping smoking and its preparation method
12/12/2007CN101085104A Application of aqueous solution containing nicotine in preparing stop smoking medicine
12/12/2007CN101085101A Orally-administered traditional Chinese medicine composition for treating intercostal neuralgia
12/12/2007CN101085062A Medicine for curing parkinson's disease and its preparing method
12/12/2007CN101084977A Traditional Chinese medicinal composition for curing facial paralysis
12/12/2007CN101084952A Method for preparing extraction of acanthopanax senticousus saponins
12/12/2007CN101084947A Sedative tea containing semen platycladi and angelica sinensis
12/12/2007CN101084946A Active component of levant cotton and preparation method and application thereof
12/12/2007CN101084925A Technology for producing pilose antler mother solution
12/12/2007CN101084924A Method for preparing goat's horn extraction
12/12/2007CN101084909A New use of ginsenoside Rg1
12/12/2007CN101084908A Compound medicine composed of gastrodin and borneol
12/12/2007CN100354426C Viral core protein-cationic lipid-nucleic acid-delivery complexes
12/12/2007CN100354307C NOGO receptor-mediated blockade of axonal growth
12/12/2007CN100354291C Novel natural drug effective region
12/12/2007CN100354281C Process for preparation of 9-amino substituted 9,10-dihydropyrrolo [2,1-b] [1,3] benzotiazepines
12/12/2007CN100354274C Medicines for prevention and treatment of neurodegenerative diseases
12/12/2007CN100354273C Novel substituted 4-phenyl-4-ú¿1h-imidazol-2-ylú®-piperidine derivatives and their use as selective non-peptide delta opioid agonists
12/12/2007CN100354267C Preventives or remedies for alzheimer's disease or amyloid protein fibrosis inhibitors containing nitrogen-containing heteroaryl compounds
12/12/2007CN100354251C Fused bicyclic or tricyclic amino acids
12/12/2007CN100353968C Chinese medicine preparation for nourishing blood and tranquilizing mind and its preparation process
12/12/2007CN100353939C Antidepressant composition containing citalopram and cyclodextrin
12/11/2007US7307164 β-amino heterocyclic dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes
12/11/2007US7307102 Administering selective estrogen receptor modulators that possesses tissue-specific ER agonist activity
12/11/2007US7307101 Administering N-hydroxy-N-(4-butyl-2-methylphenyl)-formamidine (HET0016) to increase or prevent a decrease in cerebral blood flow